Status:

COMPLETED

MASTER II - Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients

Lead Sponsor:

Medtronic Cardiac Rhythm and Heart Failure

Collaborating Sponsors:

Medtronic

Conditions:

Myocardial Infarction

Arrhythmia, Ventricular

Eligibility:

All Genders

Phase:

NA

Brief Summary

The purpose of the study is to determine the usefulness of Microvolt T Wave Alternans (MTWA) testing of patients that have had a heart attack and have decreased pumping ability of the lower chamber of...

Eligibility Criteria

Inclusion

  • Patients with a history of heart attacks
  • LVEF \>0.30 and \<= 0.40 as measured by a radionuclide study, angiography or quantitative echocardiography within 3 months prior to enrollment.

Exclusion

  • Patients with electrocardiographically documented sustained ventricular tachycardia, ventricular fibrillation or prior cardiac arrest (Class I indications)
  • Patients who have undergone an electrophysiologic study with ventricular stimulation or a MTWA test within 1 year prior to enrollment
  • Patients with medical conditions that preclude the testing required by the Investigational Plan or limit study participation
  • Patients unable to complete MTWA testing requirements due to current atrial fibrillation or flutter
  • Patients unable to exercise and for which alternative modalities (pacing or pharmacological stress) used for MTWA testing are not available
  • Patients who have experienced an MI within 1 month prior to enrollment
  • Patients with advanced cerebrovascular disease per physician's assessment
  • Patients classified as NYHA Class IV at time of enrollment
  • Patients who have undergone cardiac revascularization within 3 months prior to enrollment or are scheduled for cardiac revascularization at the time of enrollment
  • Patients with a life expectancy of less than 1 year

Key Trial Info

Start Date :

October 1 2003

Trial Type :

INTERVENTIONAL

End Date :

February 1 2007

Estimated Enrollment :

405 Patients enrolled

Trial Details

Trial ID

NCT00305214

Start Date

October 1 2003

End Date

February 1 2007

Last Update

February 13 2008

Active Locations (47)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 12 (47 locations)

1

Mobile, Alabama, United States

2

Phoenix, Arizona, United States

3

Walnut Creek, California, United States

4

Denver, Colorado, United States